Anesthetic risk associated with surgery is a common clinical challenge that most veterinarians face. Geriatrics, juveniles and patients with concurrent disease are of particular concern. Intraoperative analgesia (injectable or inhalant) and its adverse effects, has been a rich source of human and animal investigative studies. To mitigate these potential effects by reducing the amount of anesthetic used, pain relief during surgery is augmented through the use of opioids. It has been demonstrated that clinically therapeutic doses of morphine, through pain reduction, can reduce minimal alveolar concentration (MAC) of inhalation anesthetics in dogs by as much as 60%.1 The reduction of anesthetics and their associated adverse cardiovascular effects, however, comes at the cost of opioids potentially producing their own adverse effects such as vomiting/ nausea, delayed postoperative recovery and a decreased level of consciousness.